Compare ARK Genomic Revolution ETF (ARKG) vs Global X CleanTech (CTEC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Global X CleanTech — how do they compare? ARK Genomic Revolution ETF trades at $41, while Global X CleanTech trades at $59.04. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Global X CleanTech nearer its low. Which is the better fit depends on your goals.
| ARKG | CTEC | |
|---|---|---|
Sector | Sector/Thematic | Sector/Thematic |
52-Week High | $43.57 | $78.11 |
52-Week Low | $23.09 | $39.30 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
CTEC stock trades at $59.04, down 1.32% on the day, with a bearish technical signal driven by moving averages and oscillators. Key support lies at $57, with resistance at $60. Financial ratios are unavailable, but the company has a scheduled dividend of $0.07 per share payable in July 2026. Recent news coverage is limited, creating uncertainty around current business developments.
The outlook remains cautious due to weak technical momentum and lack of recent fundamental data. The dividend provides some income appeal, but investors face risks from limited visibility into financial health and market sentiment. Upside depends on future earnings reports demonstrating growth and profitability improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Global X CleanTech
CTEC invests in companies at the forefront of the clean technology industry. It focuses on disruptive innovations in renewable energy production, energy storage, smart grids, and energy efficiency, with top holdings like Enphase and First Solar.
Read more on CTEC →
